Gene · 2492
Papers3,947
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,947
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phoenixin-14 as a novel direct regulator of porcine luteal cell functions†. | Biol Reprod | 2024 | 37815939 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS). | Stem Cell Rev Rep | 2024 | 37768523 | PubTator, text mining | PubMed |
| Network pharmacology and experimental validation on yangjing zhongyu decoction against diminished ovarian reserve. | J Ethnopharmacol | 2024 | 37567422 | PubTator, text mining | PubMed |
| A Systematic Review of Genetics and Reproductive Health Outcomes: Asian Perspective. | Reprod Sci | 2024 | 37524971 | PubTator, text mining | PubMed |
| Endocrine Changes in Postmenopausal Women: A Comprehensive View. | Cureus | 2023 | 38288203 | PubTator, text mining | PubMed |
| Comparison of the Effect of BPA and Related Bisphenols on Membrane Integrity, Mitochondrial Activity, and Steroidogenesis of H295R Cells In Vitro. | Life (Basel) | 2023 | 38276253 | PubTator, text mining | PubMed |
| PGT-M for Premature Ovarian Failure Related to CGG Repeat Expansion of the FMR1 Gene. | Genes (Basel) | 2023 | 38275588 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of the Aged Nulliparous Mouse Ovary Suggests a Stress State That Promotes Pro-Inflammatory Lipid Signaling and Epithelial Cell Enrichment. | Int J Mol Sci | 2023 | 38203684 | PubTator, text mining | PubMed |
| Thiol-yne click crosslink hyaluronic acid/chitosan hydrogel for three-dimensional in vitro follicle development. | Mater Today Bio | 2023 | 38179228 | PubTator, text mining | PubMed |
| Insulin-like growth factor binding protein-1 and insulin in polycystic ovary syndrome: a systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2023 | 38174331 | PubTator, text mining | PubMed |
| Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function. | Res Sq | 2023 | 38168227 | PubTator, text mining | PubMed |
| The Effect of FSHR (G2039A) Polymorphism on Müllerian Duct Development and Hormonal Profile of Women with Primary Amenorrhea. | J Reprod Infertil | 2023 | 38164425 | PubTator, text mining | PubMed |
The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study. | Front Endocrinol (Lausanne) | 2023 | 38155955 | PubTator, text mining | PubMed |
| Androgen excess: a hallmark of polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 38152131 | PubTator, text mining | PubMed |
| Paeoniflorin Alleviates Cisplatin-Induced Diminished Ovarian Reserve by Restoring the Function of Ovarian Granulosa Cells via Activating FSHR/cAMP/PKA/CREB Signaling Pathway. | Molecules | 2023 | 38138611 | PubTator, text mining | PubMed |
| Invisible Hand behind Female Reproductive Disorders: Bisphenols, Recent Evidence and Future Perspectives. | Toxics | 2023 | 38133401 | PubTator, text mining | PubMed |
| Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study. | Sci Rep | 2023 | 38129424 | PubTator, text mining | PubMed |
| Reproductive health in Turner's syndrome: from puberty to pregnancy. | Front Endocrinol (Lausanne) | 2023 | 38116311 | PubTator, text mining | PubMed |
| CXCL10-based gene cluster model serves as a potential diagnostic biomarker for premature ovarian failure. | PeerJ | 2023 | 38107572 | PubTator, text mining | PubMed |
| Dysfunction of Human Estrogen Signaling as a Novel Molecular Signature of Polycystic Ovary Syndrome. | Int J Mol Sci | 2023 | 38069013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2492/papers?page=15